Tarnow L - Search Results

1

A single nucleotide polymorphism within the acetyl-coenzyme A carboxylase beta gene is associated with proteinuria in patients with type 2 diabetes.

Maeda S, Kobayashi MA, Araki S, Babazono T, Freedman BI, Bostrom MA, Cooke JN, Toyoda M, Umezono T, Tarnow L, Hansen T, Gaede P, Jorsal A, Ng DP, Ikeda M, Yanagimoto T, Tsunoda T, Unoki H, Kawai K, Imanishi M, Suzuki D, Shin HD, Park KS, Kashiwagi A, Iwamoto Y, Kaku K, Kawamori R, Parving HH, Bowden DW, Pedersen O, Nakamura Y. Maeda S, et al. Among authors: tarnow l. PLoS Genet. 2010 Feb 12;6(2):e1000842. doi: 10.1371/journal.pgen.1000842. PLoS Genet. 2010. PMID: 20168990 Free PMC article.

2

Renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?

Andersen S, Tarnow L, Cambien F, Rossing P, Juhl TR, Deinum J, Parving HH. Andersen S, et al. Among authors: tarnow l. Kidney Int. 2002 Jul;62(1):192-8. doi: 10.1046/j.1523-1755.2002.00410.x. Kidney Int. 2002. PMID: 12081578 Free article. Clinical Trial.

3

PC-1 amino acid variant (K121Q) has no impact on progression of diabetic nephropathy in type 1 diabetic patients.

Jacobsen P, Grarup N, Tarnow L, Parving HH, Pedersen O. Jacobsen P, et al. Among authors: tarnow l. Nephrol Dial Transplant. 2002 Aug;17(8):1408-12. doi: 10.1093/ndt/17.8.1408. Nephrol Dial Transplant. 2002. PMID: 12147787

4

Time course of the antiproteinuric and antihypertensive effect of losartan in diabetic nephropathy.

Andersen S, Jacobsen P, Tarnow L, Rossing P, Juhl TR, Parving HH. Andersen S, et al. Among authors: tarnow l. Nephrol Dial Transplant. 2003 Feb;18(2):293-7. doi: 10.1093/ndt/18.2.293. Nephrol Dial Transplant. 2003. PMID: 12543883

5

Smoking and progression of diabetic nephropathy in type 1 diabetes.

Hovind P, Rossing P, Tarnow L, Parving HH. Hovind P, et al. Among authors: tarnow l. Diabetes Care. 2003 Mar;26(3):911-6. doi: 10.2337/diacare.26.3.911. Diabetes Care. 2003. PMID: 12610058

6

Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes.

Hovind P, Tarnow L, Rossing K, Rossing P, Eising S, Larsen N, Binder C, Parving HH. Hovind P, et al. Among authors: tarnow l. Diabetes Care. 2003 Apr;26(4):1258-64. doi: 10.2337/diacare.26.4.1258. Diabetes Care. 2003. PMID: 12663607

7

Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?

Andersen S, Tarnow L, Cambien F, Rossing P, Juhl TR, Deinum J, Parving HH. Andersen S, et al. Among authors: tarnow l. Diabetes Care. 2003 May;26(5):1501-6. doi: 10.2337/diacare.26.5.1501. Diabetes Care. 2003. PMID: 12716812

8

Genetic variation in the Renin-Angiotensin system and progression of diabetic nephropathy.

Jacobsen P, Tarnow L, Carstensen B, Hovind P, Poirier O, Parving HH. Jacobsen P, et al. Among authors: tarnow l. J Am Soc Nephrol. 2003 Nov;14(11):2843-50. doi: 10.1097/01.asn.0000092139.19587.51. J Am Soc Nephrol. 2003. PMID: 14569094

9

Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.

Tarnow L, Hovind P, Teerlink T, Stehouwer CD, Parving HH. Tarnow L, et al. Diabetes Care. 2004 Mar;27(3):765-9. doi: 10.2337/diacare.27.3.765. Diabetes Care. 2004. PMID: 14988299

10

Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end points.

Parving HH, Andersen S, Jacobsen P, Christensen PK, Rossing K, Hovind P, Rossing P, Tarnow L. Parving HH, et al. Among authors: tarnow l. Semin Nephrol. 2004 Mar;24(2):147-57. doi: 10.1016/j.semnephrol.2003.11.003. Semin Nephrol. 2004. PMID: 15017527 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters